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Nucleoside diphosphate (NDP) kinases are involved in numerous regulatory processes associated
with proliferation, development, and differentiation. Previously, we cloned a new member of the
NDPK family from mouse, Nm23-M5, which encodes a 211-amino acid protein and has 86% identity
to the human Nm23-H5 [Hwang, K.C., Ok, D.W., Hong, J.C., Kim, M.O. and Kim, J.H. (2003) Cloning,
sequencing, and characterization of the murine Nm23-M5 gene during mouse spermatogenesis
and spermiogenesis. Biochem. Biophys. Res. Commun. 306, 198–207]. To better understand Nm23-
M5 function, we generated transgenic mice with reduced Nm23-M5 levels in vivo using a short hair-
pin RNA (shRNA) knock-down system. Nm23-M5 expression was markedly reduced, as indicated by
Northern and Western blot analysis. Nm23-M5 shRNA transgenic mice exhibited reduced numbers
of haploid cells. Furthermore, the antioxidant enzyme glutathione peroxidase 5 (GPX-5) is regulated
by Nm23-M5 at the level of both expression and activity. These results reveal that expression of
Nm23-M5 plays a critical role in spermiogenesis by increasing the cellular levels of GPX-5 to elimi-
nate reactive oxygen species.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction appear to possess NDPK activity and is predominantly expressedNucleoside diphosphate kinases (NDPKs) (EC 2.7.4.6) are ubiq-
uitous enzymes and catalyze the transfer of c-phosphates between
nucleoside and deoxynucleoside di- and tri-phosphates. A number
of mammalian genes that encode NDPK-like molecules (denoted
non-metastatic 23 or Nm23 genes) have been identiﬁed and cloned
[1–6]. Among the human Nm23 genes (Nm23-H1 to Nm23-H8), the
Nm23-H1 gene product has been characterized as a human NDPK A
isoform which is overexpressed in solid tumors as compared to
normal tissues [7–9]. Nm23-H2 (a NDPK B isoform) encodes Puf,
a protein which is a transcription factor for the c-myc proto-onco-
gene [2,10,11].
The overexpression of Nm23-H3 (a NDPK C isoform also called
DR-Nm23) induces apoptosis of myeloid cells and suppresses gran-
ulocyte differentiation [2,12]. Nm23-H4 (a NDPK D isoform) is a
mitochondrial speciﬁc NDPK isoform [4,13]. Nm23-H5 does notchemical Societies. Published by E
se; Nm23, non-metastatic 23;
scription PCR
).
his work.in testis, together with Nm23-H7 and Nm23-H8 [3,5]. Nm23-H6
(a NDPK F isoform) is expressed in most human tissues and
overexpression of Nm23-H6 results in growth suppression and
generation of multinucleated cells [13,14]. The Nm23-H7 gene is
located in or near the hereditary prostate cancer susceptibility
locus and has a duplicated NDP kinase domain sequence [13].
Nm23-H8 has a triplicated NDPK domain sequence and an
N-terminal sequence that is homologous to thioredoxin [6].
Recently, we reported the cloning and characterization of the
murine Nm23-M5 gene, which shares 86% identity with its human
homolog Nm23-H5 [15].
Apart from their role in nucleotide synthesis, the NDPKs in
mammalian cells are also involved in processes such as tumor
metastasis, cell proliferation, transcriptional regulation,
development, senescence, and apoptosis [3,10–12,16]. To better
understand the function of the Nm23-M5 gene, we generated
Nm23-M5 knock-down transgenic mice using a short hairpin
RNA (shRNA) vector system. The shRNA leads to degradation of
homologous mRNAs and may be used for the disruption of target
gene expression to study the function of a speciﬁc gene [17].
Because not all shRNAs are effective, we veriﬁed knock-down of
the Nm23-M5 gene by the shRNA Nm23-M5 vector in CHO cellslsevier B.V. All rights reserved.
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expression is down-regulated in Nm23-M5 shRNA transgenic mice
using RT-PCR and Western blot analysis. Nm23-M5 shRNA
transgenic mice exhibit an abnormal testis phenotype and reduced
cell numbers of haploid stage cells such as spermatids. These data
clearly demonstrate that the expression of Nm23-M5 gene is a
critical factor for spermiogenesis.2. Materials and methods
2.1. Cloning and expression of murine Nm23-M5 in CHO cells
The Nm23-M5 cDNA was inserted into the EcoRI and BglII
digested pCXN2 expression vector (pCXN2-Nm23-M5). The
pCXN2-Nm23-M5 vector was digested with PvuI, puriﬁed using a
gel extraction kit (Solgent, Daejeon, Korea), and then used for cell
transfection. CHO cells were transfected with 10 lg of pCXN2-
Nm23-M5 using Effectene (Qiagen, Valencia, CA, USA) and selected
in the presence of G418 (700 lg/ml) for 30 days. Stable cell lines
harboring the Nm23-M5 gene were chosen by limiting dilution
and were conﬁrmed by Western blot analysis. Stable CHO cell lines
which expressed the Nm23-M5 gene were plated at a density of
2  105 cells per 35-mm dish and grown with McCoy’s 5A medium
containing 10% FBS.2.2. Design and cloning of shRNA against murine Nm23-M5
Oligonucleotides which target nucleotides 256–277 of the
Nm23-M5 transcript (NCBI accession no: AF343565) were synthe-
sized. The complementary oligonucleotides were annealed and
ligated into the pU6shx vector (Vector corea, Seoul, Korea), which
contains the human U6 RNA polymerase III promoter and a
neomycin resistance gene (pU6shx-Nm23-M5). The sequences of
the oligonucleotides were 50-GACATAAGGCCATCTCCTACTTTCGA-
GTAG- GAGATGGCCTTATGTC-30 (sense) and 50-GACATAAGGCCA-
TCTCCTA- CTCGAAAGTAGGAGATGGCCTTATGTC-30 (antisense).
The pU6shx-Nm23-M5 vector was digested with XbaI and EcoRI,
puriﬁed using a gel extraction kit (Solgent, Daejeon, Korea) and
then used for cell transfection and/or production of transgenic
mice.2.3. Production of Nm23-M5 polyclonal and monoclonal antibodies
For polyclonal antibody production, rabbits were injected
with afﬁnity-puriﬁed Nm23-M5 protein, initially with complete
Freund’s adjuvant and subsequently with incomplete Freund’s
adjuvant. Polyclonal antibodies from serum were puriﬁed using a
Protein G Sepharose column (Amersham Pharmacia, Orsay, France)
and tested for Nm23-M5 recognition by ELISA. The method of
Kohler and Milstein [18] was adapted to produce monoclonal
antibodies. The isotypes of the selected monoclonal antibodies
were determined using a commercially available isotyping kit
(Roche Diagnostics, Mannheim, Germany).
2.4. Real time RT-PCR, Northern blot, Western blot, and
immunohistochemical analysis
Total RNA was isolated from adult testis tissues using the
TRIZOL reagent (Gibco BRL). In order to speciﬁcally detect the
expression of Nm23-M5 cDNA transcripts, RT-PCR was performed
with speciﬁc primers using a Peltier Thermal Cycler 200 (MJ Re-
search, Nevada, USA). Nm23-M5 cDNA detection was performed
using the following primers: (forward) 50- ATGGGGGTGCAC-
GAATGTCC-30 and (reverse) 50-TCATCTGTCCCCTGTCCTGC-30.Northern blot, Western blot, and immunohistochemical analyses
were designed as described previously [15,20,21].
2.5. Generation of heterozygous and homozygous transgenic mice
Transgenic mice were produced as described previously [20].
All experiments were performed under the Animal Care guidelines
of the Konkuk University. Heterozygous transgenic mice were
conﬁrmed by PCR using the following primers: forward,
50-TTTATGCTTCCGGCTCGTAT-30, and reverse, 50-CGTAATACGACTC-
ACTATAGG-30. For the production of homozygous transgenic mice,
heterozygous male and female transgenic mice were mated.
Homozygous transgenic mice were selected and conﬁrmed by
PCR, and the level of Nm23-M5 gene expression was determined.
2.6. Nm23-M5 and mGPX-5 modeling
The comparative modeling program MODELLER v8 [29] was
used to generate structural models for Nm23-M5 and mGPX-5.
The available crystal structures of the human NDPK A (PDB ID:
1JXV, sequence identity 28%) and the human GPX-5 (PDB ID:
2I3Y, sequence identity 30%) were used as the templates during
the homology building process. A ﬁrst set of twenty crude struc-
tures was automatically generated with MODELLER using the
default options. The best model with the lowest MODELLER re-
straint energy was kept and further reﬁned by energy minimiza-
tion using the CNS program [30]. The stereochemistry of the ﬁnal
model was validated by PROCHECK [31]. A binding model structure
(NM23-M5 and mGPX-5) was built using the HEX 4.5 program. The
iterative steps of model building by the ‘‘O” program [32] and
energy minimization using CNS yielded a ﬁnal model, displayed
by PyMOL [33].
2.7. Statistical analysis
Values are reported as means ± standard deviation. Compari-
sons were performed by ANOVA. At least three independent
experiments were performed. A value of P < 0.05 was considered
signiﬁcant.3. Results
3.1. Nm23-M5 shRNA knock-down of Nm23-M5 expression at the
transcriptional and translational levels in CHO cells expressing Nm23-
M5
A stable CHO cell line harboring the Nm23-M5 gene (a testis
speciﬁc NDPK isoform) was established. To verify the constitutive
expression of Nm23-M5, we examined the presence of Nm23-M5
transcripts and protein through Northern blot and Western blot
analysis, respectively (Fig. 1A). Fig. 1B shows the protein levels of
Nm23-M5 in CHO cells after transfection, indicating that the CHO
cells stably expressed the Nm23-M5 gene.
Nm23-M5 gene knock-down was achieved using a vector-based
shRNA approach. A Nm23-M5 shRNA corresponding to nucleotides
256–277 of the murine Nm23-M5 cDNA sequence was designed
and conﬁrmed by BLAST similarity search to minimize off-target
effects. To examine whether the Nm23-M5 shRNA expression vec-
tor was effective in knocking-down Nm23-M5 expression, differ-
ent concentrations (0, 1, 5 and 10 nM) of Nm23-M5 shRNA were
transfected into a CHO cell line stably expressing Nm23-M5. A
treatment of approximately 10 nM Nm23-M5 shRNAwas sufﬁcient
to completely down-regulate the Nm23-M5 gene, indicating that
the Nm23-M5 shRNA expression vector efﬁciently knocks-down
the Nm23-M5 gene (Fig. 1).
Fig. 1. Nm23-M5 expression pattern in mouse and shRNA silencing of Nm23-M5 expression. (A) Expression pattern of Nm23-M5 in various murine tissues by Western blot.
B, brain; H, heart; K, kidney; Li, liver; Lu, lung; S, spleen; O, ovary; and T, testis. (B) Establishment of a stable CHO cell line for Nm23-M5 expression. (C) Construction of a
Nm23-M5 shRNA expression vector for the production of transgenic mice. (D) Secondary structure prediction for the Nm23-M5 shRNA. (E and F) Nm23-M5 down-regulation
by treatment with various Nm23-M5 shRNA concentrations was detected by Northern or Western blot analysis of CHO cells stably expressing Nm23-M5.
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spermatids in the mouse testis
To knock-down Nm23-M5 expression in haploid stages, we pro-
duced transgenic mice. Heterozygotes were produced by microin-
jection and conﬁrmed by PCR (Fig. 2). Homozygotes were produced
by mating female and male transgenic mice. To conﬁrm the levels
of Nm23-M5 gene expression in transgenic mouse testes, we per-
formed Western blots (Fig. 3A) and real-time RT-PCR (Fig. 3B).
Nm23-M5 gene expression was signiﬁcantly down-regulated in
the Nm23-M5 shRNA transgenic mouse testes compared to those
of control mouse testes. The expression of Nm23-M5 in homozy-
gous shRNA transgenic mice was approximately half of that de-
tected in heterozygotes (Fig. 3).Fig. 2. Production of transgenic mice expressing the Nm23-M5 shRNA. (A) Comparison o
shRNA. (B) Primer design for identiﬁcation of transgenic mice harboring the Nm23-M5
analysis (M: size marker, N: negative control, P: positive control, lanes 1–11: individualThe full-length Nm23-M5 protein fused to a hexahistidine tag at
the NH2 terminus was expressed [19] and puriﬁed as described by
Yu et al. [17] and used as immunogen to raise polyclonal antibod-
ies in rabbits. These afﬁnity-puriﬁed antibodies speciﬁcally recog-
nize Nm23-M5, as shown by Western blotting (Fig. 1A). Our
previous study showed that Nm23-M5 mRNA expression was ﬁrst
detected at day 15 after birth, when primary spermatocytes in the
early pachytene stage of meiosis are the most advanced germ cells
present in the testis. In this study, we further characterized the
cellular localization of Nm23-M5 in testes sections of adult testis.
Nm23-M5 protein expression was strongly localized in round
and elongated spermatids, with lesser staining on spermatocytes.
Somatic cells, such as the Sertoli and Leydig cells, were negative
(Fig. 3C, left panels). In elongating spermatids, Nm23-M5 isf testis phenotype between wild type and transgenic mice harboring the Nm23-M5
shRNA by PCR analysis. (C) Identiﬁcation of transgenic mice (596 bp size) by PCR
pups tested).
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Fig. 3. Disruption of Nm23-M5 gene expression results in defects in spermiogenesis. (A) RT-PCR analysis shows the down-regulation of Nm23-M5 gene expression in the
Nm23-M5 shRNA transgenic mouse testis. (B) Western blot analysis shows the down-regulation of Nm23-M5 gene expression in the Nm23-M5 shRNA transgenic mouse
testis. (C) Abnormal testis phenotype in Nm23-M5 shRNA transgenic mice. Scale bars = 20 lm. S, Sperm; Es, elongating spermatids; P, pachytene spermatocyte; Rs, round
spermatids; Sc, Sertoli cell; Sg, spermatogonium; and V, vacuoles.
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tected in the head and the ﬂagellum. Additionally, Nm23-M5 in
ejaculated spermatozoa is present primarily at the base of the
mid-piece and along the ﬂagellum, and in decreasing amounts in
the sperm head. However, Nm23-M5 shRNA heterozygous and
homozygous transgenic mice exhibited an abnormal testis pheno-
type and reduced cell numbers, especially of round and elongated
spermatids (Fig. 3C, right panels).
3.3. Nm23-m5 silencing results in the down-regulation of GPX-5 and
depletion of round and elongated spermatids
Bax induces apoptosis due to the generation of ROS. We hypoth-
esized that Nm23-M5 might serve to protect the testis from oxida-
tive stress. To test this hypothesis, we examined whether
overexpression of this gene in CHO cells, which do not normally
express Nm23-M5, would enhance antioxidant activity in order
to suppress ROS-induced apoptosis. A Nm23-M5-expressing CHO
cell line was established by transfection with an expression vector
containing a mouse Nm23-M5 cDNA under the control of the cyto-megalovirus promoter (CMV/Nm23-M5) (Fig. 4C). A control CHO
cell line was transfected with the CMV-neo expression vector
alone. We assessed the transcript levels of nine antioxidant en-
zymes, including those belonging to the superoxide dismutase
(SOD), catalase, and glutathione peroxidase (GPX) families. CMV/
Nm23-M5-transfected cells showed altered expression proﬁles of
several antioxidant enzymes. Expression of GPX-5, which catalyzes
conversion of hydrogen peroxide to water, was highly increased
(4-fold) in the CMV/Nm23-M5-transfected cells. Therefore, we
examined apoptosis in CMV/Nm23-M5-transfected cells and con-
trol cells by adding H2O2 to the culture medium. As shown in
Fig. 4D, CMV/Nm23-M5-transfected cells were resistant to cell
death, but control cells were not.
We further explored whether Nm23-M5 silencing resulted in
in vivo changes in expression of GPX-2 and -5. A real-time RT-
PCR assay showed that GPX-2 and -5 mRNAs were signiﬁcantly
down-regulated in the testis of Nm23-M5 shRNA transgenic mice
(Fig. 4A and B). Real-time RT-PCR analyses revealed that GPX-5
expression decreased by 20% and 60% in Nm23-M5 shRNA hetero-
zygous and homozygous transgenic testes, respectively. Also, testis
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cially round and elongated spermatids, compared to those of het-
erozygous transgenic and control mice.
To better understand the structural basis of the interaction be-
tween Nm23-M5 and mGPX-5, we generated homology model
structures of NM23-M5 and mGPX-5. A possible interaction be-
tween Nm23-M5 and mGPX-5 was predicted using a docking sim-
ulation program. This result suggests that the C-terminal extension
region may mediate the speciﬁc interaction between Nm23-M5
and GPX-5 (Fig. 4E). Considering that antioxidants protect cells
against oxidative DNA damage, our results suggest that Nm23-
M5 plays an important role in spermiogenesis by providing protec-
tion via GPX-5 against damage induced by ROS.
4. Discussion
In this study, we investigated the mechanism by which Nm23-
M5 protects CHO cells in vitro and male haploid germ cells in vivo
against oxidative stress-induced apoptosis. Speciﬁcally, we focused
on the level of expression and the C-terminal region of Nm23-M5
in protection against oxidative stress-induced apoptosis. We also
explored the relationship between Nm23-M5 and GPX-5 during
oxidative stress. Our results indicate that a high level of Nm23-
M5 expression and Nm23-M5 protein in cells is critical to theirprotection against oxidative stress-induced apoptosis. When
Nm23-M5 expression was reduced by a Nm23-M5 speciﬁc shRNA,
round and elongated spermatids in testes of transgenic mice were
signiﬁcantly more sensitive to oxidative stress. In contrast, overex-
pression and maintenance of high levels of Nm23-M5 in CHO cells
signiﬁcantly increased resistance to oxidative stress.
The knock-down approach is useful for clarifying the physiolog-
ical role of molecules in vivo [17]. To examine the effects of a loss-
of function of Nm23-M5 in vivo, we used a Nm23-M5 short hairpin
RNA (shRNA) to knock-down the expression in the testes of trans-
genic mice. The Nm23-M5 shRNA knocked-down the expression of
Nm23-M5 and reduced the Nm23-M5 protein level in haploid
spermatids derived from Nm23-M5 shRNA transgenic mice, as
shown by RT-PCR and Western blot, respectively. More impor-
tantly, the reduction of Nm23-M5 expression resulted in a de-
crease in survival of round and elongated spermatids, as well as
a decrease in expression of GPX-5. In the testis, GPX-5 has been
used extensively as an indicator ROS scavenger activity in the tes-
tes of rodents and human. Our results suggest that after knock-
down of Nm23-M5, the testes were severely damaged and haploid
spermatids were rarely found.
The testis is sensitive to a variety of stressors, such as hyper-
thermia, inﬂammation, radiation, and oxidative stress [22–24].
Oxidative stress in the testis induces germ cell apoptosis and sev-
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mine E) have been shown to protect germ cells against oxidative
DNA damage [25–28]. In our previous study, we reported that
the overexpression of Nm23-M5 in ﬁbroblasts enhanced cellular
levels of several antioxidant enzymes, particularly glutathione per-
oxidase 5. Therefore, we hypothesized that Nm23-M5 controls the
expression of glutathione peroxidase 5 in some way and that
upregulation of antioxidant function serves to protect spermmem-
branes from oxidative damage [15].
Nm23-M5 mRNA expression was ﬁrst detected at day 15 after
birth, a time when primary spermatocytes in the early pachytene
stage of meiosis are the most advanced germ cells present in the
testis [15]. Therefore, we characterized the level of the Nm23-M5
protein more precisely to assess the differences in the expression
of these two genes. A high level of Nm23-M5 protein is found only
in round and elongated spermatids, depending on the stage of tu-
bules, and is not observed outside of the testicular tubules; Nm23-
M5 is not detected in spermatogonia or somatic cells. This expres-
sion pattern may reﬂect the cell-speciﬁc and/or stage-speciﬁc
expression of Nm23-M5 in haploid cells. Thus, the murine
Nm23-M5 mRNA appears to be somewhat differently expressed
than its human counterpart.
In the testis of Nm23-M5 gene knock-down transgenic mice,
expression of GPX-5 was profoundly down-regulated. GPX-5 is a
24-kDa secretory protein that acts independently of selenium
and is expressed in the caput epididymis under the control of
androgens [30,31]. The protein has been shown to bind to the acro-
somic region of spermatozoa in the epididymis [32]. At that stage,
GPX-5 behaves in vivo and in vitro as a glutathione peroxidase
[33]. Thus, we hypothesize that Nm23-M5 controls the expression
of GPX-5 and that this upregulation of antioxidant function serves
to protect sperm membranes from oxidative damage.
In this study, we employed a shRNA knock-down system to ana-
lyze the functional role of the Nm23-M5 gene in transgenic mice.
The Nm23-M5 shRNA heterozygous and homozygous transgenic
mice exhibited an abnormal testis phenotype and signiﬁcantly re-
duced cell numbers, particularly spermatids. Most likely, this cell
death can be explained by the down-regulation in Nm23-M5
expression, in which Nm23-M5 is not present to activate glutathi-
one peroxidase 5 expression, rendering the Nm23-M5 shRNA
homozygous transgenic mice much more susceptible to oxidative
DNA damage. At present, the mechanisms of spermatid cell death
by Nm23-M5 knock-down are not clear, but previous experimental
data on Nm23-M5 [15] allow us to hypothesize that increased oxi-
dative stress by inactivation of glutathione peroxidase 5 leads to
cell death. However, further study is needed to reveal the mecha-
nism of glutathione peroxidase 5 activation by Nm23-M5 gene
expression during spermiogenesis. These experiments are cur-
rently ongoing in our laboratory.
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